A survey of hospitals participating in the Canadian Nosocomial Infection Surveillance Program suggests that these facilities are not adequately prepared for Candida auris, according to an article on the Healio website.
The first multidrug-resistant case of the illness was reported in the country in 2017.
To date, no program has been implemented for systematic surveillance of C. auris in Canada, and data to inform best practices in microbiology and infection prevention and control (IPAC) remain sparse, the article said.
Of the 56 hospitals, 10 had a written policy stating which patients should be screened for C. auris colonization; an additional 11 hospitals suggested some patient screening was needed.
Rethinking How Healthcare Facilities Fund Construction Projects
Winners Named for the 15th Annual Healthcare Design Awards
Intermountain Health Breaks Ground on New Children's Hospital in Nevada
Ambulatory Care Facilities Reshape FM Strategies
Intermountain Foundation Receives $150M Gift for Children's Hospital in Nevada